Reaction
Low Turnover Osteopathy reporting signals
As of the last recalculation, Low Turnover Osteopathy appears in 3,999 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is ALENDRONATE SODIUM (PRR 3,302.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alendronate Sodium | 3,765 | 3,302.6 | 3,431.3 |
| Risedronate Sodium | 517 | 99.3 | 100.9 |
| Ascorbic Acid | 110 | 25.3 | 25.4 |
| Raloxifene Hydrochloride | 52 | 18.8 | 18.8 |
| Vitamin E | 97 | 16.4 | 16.5 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 56 | 12.5 | 12.5 |
| Alendronate Sodium Tablet | 34 | 9.6 | 9.6 |
| Conjugated Estrogens | 101 | 9.2 | 9.2 |
| Estrogens, Conjugated | 100 | 9.0 | 9.0 |
| Zoledronic Acid | 65 | 8.6 | 8.6 |
| Salmeterol Xinafoate | 11 | 6.7 | 6.7 |
| Ezetimibe And Simvastatin | 18 | 6.2 | 6.2 |
| Cyanocobalamin | 35 | 5.6 | 5.6 |
| Antacid | 49 | 5.4 | 5.4 |
| Calcium Carbonate | 64 | 5.0 | 5.0 |
| Valsartan And Hydrochlorothiazide | 11 | 4.2 | 4.2 |
| Niacin | 9 | 4.0 | 4.0 |
| Rabeprazole Sodium | 21 | 4.0 | 4.0 |
| Fexofenadine Hcl | 7 | 3.9 | 3.9 |
| Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl | 34 | 3.6 | 3.6 |
| Lovastatin | 15 | 3.0 | 3.0 |
| Loratadine And Pseudoephedrine Sulfate | 4 | 2.6 | 2.6 |
| Fluticasone Propionate And Salmeterol | 20 | 2.5 | 2.5 |
| Medroxyprogesterone Acetate | 18 | 1.9 | 1.9 |
| Teriparatide | 39 | 1.8 | 1.8 |